Total Payments
$2,350
2024 Payments
$323.70
Companies
22
Transactions
107
Medicare Patients
33,990
Medicare Billing
$3.6M
Payment Breakdown by Category
Food & Beverage$2,265 (96.4%)
Education$84.99 (3.6%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,265 | 106 | 96.4% |
| Education | $84.99 | 1 | 3.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AbbVie Inc. | $576.68 | 24 | $0 (2023) |
| Janssen Biotech, Inc. | $286.75 | 17 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $237.94 | 12 | $0 (2024) |
| GENZYME CORPORATION | $207.74 | 6 | $0 (2024) |
| PFIZER INC. | $188.21 | 11 | $0 (2023) |
| Lilly USA, LLC | $164.19 | 5 | $0 (2021) |
| Genentech USA, Inc. | $126.57 | 8 | $0 (2021) |
| Regeneron Healthcare Solutions, Inc. | $97.69 | 4 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $91.08 | 1 | $0 (2018) |
| LEO Pharma Inc. | $60.79 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $323.70 | 15 | Novartis Pharmaceuticals Corporation ($73.02) |
| 2023 | $296.40 | 12 | Janssen Biotech, Inc. ($101.68) |
| 2022 | $406.92 | 17 | ABBVIE INC. ($121.49) |
| 2021 | $293.04 | 16 | GENZYME CORPORATION ($62.94) |
| 2020 | $178.32 | 10 | Novartis Pharmaceuticals Corporation ($53.24) |
| 2019 | $318.94 | 9 | Lilly USA, LLC ($105.41) |
| 2018 | $302.59 | 18 | Janssen Scientific Affairs, LLC ($91.08) |
| 2017 | $229.95 | 10 | AbbVie, Inc. ($198.63) |
All Payment Transactions
107 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/31/2024 | Biofrontera Inc. | AMELUZ (Drug), BF-RhodoLED, XEPI | Food and Beverage | Cash or cash equivalent | $15.98 | General |
| Category: DERMATOLOGY | ||||||
| 09/05/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $14.83 | General |
| 09/04/2024 | Biofrontera Inc. | AMELUZ (Drug), BF-RhodoLED, XEPI | Food and Beverage | Cash or cash equivalent | $14.97 | General |
| Category: DERMATOLOGY | ||||||
| 08/29/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $19.58 | General |
| Category: Immunology | ||||||
| 08/15/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $26.45 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 08/14/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $28.55 | General |
| Category: Dermatology | ||||||
| 07/31/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $17.62 | General |
| Category: Inflammation | ||||||
| 07/24/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $28.51 | General |
| Category: DERMATOLOGY | ||||||
| 06/20/2024 | Biofrontera Inc. | AMELUZ (Drug), BF-RhodoLED, XEPI | Food and Beverage | Cash or cash equivalent | $17.01 | General |
| Category: DERMATOLOGY | ||||||
| 06/14/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.89 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 03/28/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $14.06 | General |
| 03/14/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $30.41 | General |
| Category: Dermatology | ||||||
| 02/22/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $22.47 | General |
| Category: DERMATOLOGY | ||||||
| 02/07/2024 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $34.53 | General |
| Category: Immunology | ||||||
| 01/19/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $13.84 | General |
| Category: Immunology | ||||||
| 12/06/2023 | Janssen Biotech, Inc. | REMICADE (Biological), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $16.69 | General |
| Category: Immunology | ||||||
| 11/14/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Education | In-kind items and services | $84.99 | General |
| Category: Immunology | ||||||
| 10/06/2023 | Verrica Pharmaceuticals Inc. | YCANTH (Drug) | Food and Beverage | In-kind items and services | $17.25 | General |
| Category: DERMATOLOGY | ||||||
| 09/21/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPEVIGO (Drug) | Food and Beverage | In-kind items and services | $16.58 | General |
| Category: IMMUNOLOGY | ||||||
| 08/31/2023 | AbbVie Inc. | SKYRIZI (Biological), HUMIRA | Food and Beverage | In-kind items and services | $16.07 | General |
| Category: IMMUNOLOGY | ||||||
| 06/07/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $20.93 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 05/10/2023 | PFIZER INC. | EUCRISA (Drug), CIBINQO | Food and Beverage | In-kind items and services | $15.63 | General |
| Category: DERMATOLOGY | ||||||
| 05/03/2023 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $25.89 | General |
| Category: IMMUNOLOGY | ||||||
| 04/26/2023 | Sebela Pharmaceuticals Inc. | NAFTIN (Drug) | Food and Beverage | In-kind items and services | $14.45 | General |
| Category: DERMATOLOGY - TOPICAL CORTICOSTEROIDANSTHETIC | ||||||
| 04/20/2023 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $32.28 | General |
| Category: DERMATOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 39 | 7,897 | 18,087 | $2.7M | $902,944 |
| 2022 | 37 | 8,076 | 18,337 | $2.5M | $853,921 |
| 2021 | 37 | 8,742 | 19,232 | $2.6M | $907,715 |
| 2020 | 42 | 9,275 | 19,756 | $2.7M | $932,317 |
Total Patients
33,990
Total Services
75,412
Medicare Billing
$3.6M
Procedure Codes
155
All Medicare Procedures & Services
155 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 1,065 | 3,106 | $441,720 | $157,087 | 35.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 1,093 | 1,614 | $301,503 | $105,173 | 34.9% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 818 | 1,119 | $235,110 | $85,372 | 36.3% |
| 13132 | Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm | Office | 2023 | 140 | 171 | $168,932 | $66,478 | 39.4% |
| 13121 | Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | Office | 2023 | 124 | 162 | $143,969 | $55,971 | 38.9% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 994 | 1,404 | $195,573 | $53,996 | 27.6% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 228 | 349 | $129,970 | $39,896 | 30.7% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 235 | 296 | $104,211 | $38,587 | 37.0% |
| 13101 | Complicated repair of wound of trunk, 2.6-7.5 cm | Office | 2023 | 93 | 112 | $93,103 | $36,445 | 39.1% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 411 | 851 | $88,843 | $35,221 | 39.6% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 888 | 6,693 | $90,553 | $35,075 | 38.7% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 156 | 204 | $104,169 | $20,759 | 19.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 358 | 451 | $52,738 | $18,873 | 35.8% |
| 17272 | Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | Office | 2023 | 93 | 114 | $44,794 | $15,225 | 34.0% |
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | Office | 2023 | 138 | 215 | $37,501 | $14,891 | 39.7% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Office | 2023 | 138 | 184 | $37,313 | $14,211 | 38.1% |
| 17261 | Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | Office | 2023 | 120 | 157 | $48,215 | $14,157 | 29.4% |
| 17282 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | Office | 2023 | 65 | 80 | $34,363 | $12,249 | 35.6% |
| 11642 | Removal of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | Office | 2023 | 85 | 103 | $57,756 | $11,670 | 20.2% |
| 17263 | Destruction of cancer skin growth of trunk, arms, or legs, 2.1-3.0 cm | Office | 2023 | 53 | 61 | $24,523 | $8,790 | 35.8% |
| 17281 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm | Office | 2023 | 51 | 56 | $21,060 | $7,402 | 35.1% |
| 11622 | Removal of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | Office | 2023 | 60 | 64 | $33,800 | $6,763 | 20.0% |
| 13131 | Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 1.1-2.5 cm | Office | 2023 | 20 | 20 | $16,255 | $6,395 | 39.3% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 70 | 75 | $17,587 | $5,964 | 33.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 65 | 65 | $15,245 | $4,892 | 32.1% |
About Dr. Mazen Daoud, MD
Dr. Mazen Daoud, MD is a Dermatopathology healthcare provider based in Fort Myers, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1316903560.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mazen Daoud, MD has received a total of $2,350 in payments from pharmaceutical and medical device companies, with $323.70 received in 2024. These payments were reported across 107 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($2,265).
As a Medicare-enrolled provider, Daoud has provided services to 33,990 Medicare beneficiaries, totaling 75,412 services with total Medicare billing of $3.6M. Data is available for 4 years (2020–2023), covering 155 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatopathology
- Location Fort Myers, FL
- Active Since 04/25/2006
- Last Updated 02/27/2009
- Taxonomy Code 207ND0900X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1316903560
Products in Payments
- Humira (Biological) $293.22
- EUCRISA (Drug) $188.21
- DUPIXENT (Biological) $171.15
- Tremfya (Drug) $166.97
- TALTZ (Drug) $164.19
- SKYRIZI (Biological) $135.13
- TREMFYA (Drug) $131.78
- Erivedge (Biological) $126.57
- COSENTYX (Biological) $110.62
- LIBTAYO (Biological) $93.37
- RINVOQ (Biological) $80.34
- HUMIRA (Biological) $61.88
- ADBRY (Biological) $60.79
- COSENTYX (Drug) $58.96
- REMICADE (Biological) $58.59
- Otezla (Drug) $58.10
- AMELUZ (Drug) $47.96
- Cimzia (Drug) $37.84
- SPEVIGO (Drug) $35.56
- VTAMA (Drug) $22.47
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.